Skip to content

Insider · CIK 0001788249

Randall B. Brenner

officer

Files at PRTK (Paratek Pharmaceuticals, Inc.). First filing Nov 1, 2022, latest Dec 22, 2022.

In brief

Randall B. Brenner files SEC Form 4 as officer at PRTK (Paratek Pharmaceuticals, Inc.). Since Nov 1, 2022, Randall B. Brenner has reported 0 open-market buys worth $0 and 3 open-market sells worth $79k, the latest filed on Dec 22, 2022.

A track record needs three past buys with six months of prices behind them; Randall B. Brenner has 0, so none is measured yet.

The newest scored trade: sold $9,033 of PRTK on Dec 21, 2022, filed Dec 22, 2022, scored 10 (weak), under a 10b5-1 plan.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $79k sold

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
10Weak
PRTKsell 510b5-1
Paratek Pharmaceuticals, Inc.
$9,033
4,539 shares
-1%-
17Weak
PRTKsell 510b5-1
Paratek Pharmaceuticals, Inc.
$58k
29,282 shares
-8%-
10Weak
PRTKsell 510b5-1
Paratek Pharmaceuticals, Inc.
$12k
3,516 shares
-1%-

Transactions

Every row this insider has filed, 6 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Dec 20, 2022PRTK
Paratek Pharmaceuticals, Inc.
AGrant or award
Common Stock
+15,000$0.00$0339,851Dec 22, 2022
Dec 21, 2022PRTK
Paratek Pharmaceuticals, Inc.
SOpen-market sale
Common Stock10b5-1
-4,539$1.99$9,033335,312Dec 22, 2022
Dec 12, 2022PRTK
Paratek Pharmaceuticals, Inc.
SOpen-market sale
Common Stock10b5-1
-11,105$1.98$22k343,028Dec 14, 2022
Dec 13, 2022PRTK
Paratek Pharmaceuticals, Inc.
SOpen-market sale
Common Stock10b5-1
-18,177$1.96$36k324,851Dec 14, 2022
Oct 28, 2022PRTK
Paratek Pharmaceuticals, Inc.
SOpen-market sale
Common Stock10b5-1
-3,516$3.47$12k354,133Nov 1, 2022
Oct 25, 2022PRTK
Paratek Pharmaceuticals, Inc.
AGrant or award
Common Stock
+8,500$0.00$0357,649Oct 27, 2022

Questions about Randall B. Brenner

Answered from the filings on this page, as of the latest one.

Is Randall B. Brenner buying or selling?

Not in the last 12 months. Randall B. Brenner's latest open-market trade on SEC Form 4 was sold $9,033 of PRTK on Dec 21, 2022.

How did Randall B. Brenner's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Randall B. Brenner has 0.

Where does Randall B. Brenner file Form 4?

Randall B. Brenner has filed Form 4 at PRTK (Paratek Pharmaceuticals, Inc.) as Chief Development & Regulatory. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Randall B. Brenner: insider trades and track record | InsiderTell